BioAxone is committed to applying a deep understanding of axon regeneration and neuronal signaling pathways to transform the lives of patients afflicted with neurotrauma or neurovascular disorders. Led by a passionate management team augmented by 20 years of pioneering research, the company has identified and is developing a pipeline of drugs focused on nerve repair and regeneration.
View Top Employees from BioAxone BioSciences, Inc.Website | http://www.bioaxonebio.com |
Revenue | $2 million |
Employees | 9 (2 on RocketReach) |
Founded | 2011 |
Address | 763E Concord Avenue, Cambridge, Massachusetts 02138, US |
Phone | (617) 401-3115 |
Technologies |
JavaScript,
PHP,
Font Awesome
+7 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Spinal Cord Injury, Healthcare, Science and Engineering, Neurotrauma, Neuroregeneration, Drug Manufacturing & Research, Neuroprotection |
Web Rank | 27 Million |
Competitors | Angiochem, Curemark, LLC, GLIKNIK INC., Galmed Pharmaceuticals Ltd., Karus Therapeutics Limited |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular BioAxone BioSciences, Inc. employee's phone or email?
The BioAxone BioSciences, Inc. annual revenue was $2 million in 2024.
Lisa Bond is the Senior Director of Clinical and Regulatory Affairs of BioAxone BioSciences, Inc..
2 people are employed at BioAxone BioSciences, Inc..
BioAxone BioSciences, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for BioAxone BioSciences, Inc. are [5417, 541714, 541, 54171, 54].
The SIC codes for BioAxone BioSciences, Inc. are [873, 87].